Modeling High-Grade Serous Ovarian Carcinogenesis from the Fallopian Tube
Open accessAbstract
High-grade serous ovarian carcinoma (HGSOC) is a lethal disease for which improved screening and treatment strategies are urgently needed. Progress in these areas is impeded by our poor understanding of HGSOC pathogenesis. Most ovarian cancer research is based on the hypothesis that HGSOC arises from ovarian surface epithelial cells. However, recent studies suggest that >50% of high-grade serous carcinomas involving the ovary likely arise from fallopian tube epithelium. Therefore, limiting HGSOC research to modeling based on ovarian surface epithelium alone is inadequate. To address the need for a fallopian tube-based model of HGSOC, we have developed a system for studying human fallopian tube secretory epithelial cell (FTSEC) transformation. Our model is based on (i) immortalization of FTSECs isolated from primary samples of normal, nondiseased human fallopian tubes, (ii) transformation of FTSECs with defined genetic elements, and (iii) xenograft-based tumorigenic assays. We use our model to show that FTSECs immortalized with human telomerase reverse transcriptase (hTERT) plus SV40 large T and small T antigens are transformed by either oncogenic Ras (H-Ras(V12)) or c-Myc expression, leading to increased proliferation, clonogenicity, and anchorage-independent growth. Additionally, we demonstrate that FTSECs remain susceptible to c-Myc-mediated transformation in the absence of viral oncoproteins, by replacing SV40 large T and small T antigens with sh-p53, mutant CDK4 (CDK4(R24C)), and sh-PP2A-B56γ. Importantly, all transformed FTSECs gave rise to high-grade Müllerian carcinomas that were grossly, histologically, immunophenotypically, and genomically similar to human HGSOC. With this model, we will now be able to assess the transformative effects of specific genetic alterations on FTSECs in order to characterize their respective roles in HGSOC development.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many, perhaps most, high-grade serous ovarian cancers originate in the fallopian tube as serous tubal intraepithelial carcinomas, shedding onto the surface of the ovary and establishing a tumor.
“Many, perhaps most, HGSOC originate in the fallopian tube as Serous Tubal Intraepithelial Carcinomas (STICs), shedding onto the surface of the ovary and establishing a tumor (Crum et al., 2007; Karst et al., 2011; Perets and Drapkin, 2016; Zhang et al., 2019).”
From Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine (2022) · cites this paper as Karst et al., 2011
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709 · see citing works
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · see citing works
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,850 · see citing works
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467 · see citing works
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B. T., & Mills, G. B. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2644 · Cited by 1,353 · see citing works
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C. M., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,114 · see citing works
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C. M., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 913 · see citing works
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M. R., Medeiros, F., Saleemuddin, A., Garber, J. E., Birch, C., Mou, H., Gordon, R., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 897 · see citing works
Self-citationGrading Ovarian Serous Carcinoma Using a Two-Tier System
Malpica, A. L., Deavers, M. T., Lu, K. H., Bodurka, D. C., Atkinson, E. N., Gershenson, D. M., & Silva, E. G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00009 · Cited by 671 · see citing works
Ovarian Low-grade and High-grade Serous Carcinoma
Vang, R., Shih, I., & Kurman, R. J. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181b4fffa · Cited by 562 · see citing works
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
Seidman, J. D., Horkayne‐Szakaly, I., Haiba, M., Boice, C. R., Kurman, R. J., & Ronnett, B. M. (2003) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000101080.35393.16 · Cited by 555 · see citing works
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462 · see citing works
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Levanon, K., Crum, C., & Drapkin, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1107 · Cited by 412 · see citing works
Self-citationAre All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I., & VANG, R. S. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ef7b16 · Cited by 410 · see citing works
Cellular transformation by SV40 large T antigen: interaction with host proteins
Ali, S. H., & DeCaprio, J. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0342 · Cited by 367 · see citing works
The cell of origin of ovarian epithelial tumours
Dubeau, L. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70308-5 · Cited by 363 · see citing works
Identification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325 · see citing works
Ovarian Cancer Pathogenesis: A Model in Evolution
Karst, A. M., & Drapkin, R. (2009) · Journal of Oncology · doi:10.1155/2010/932371 · Cited by 298 · see citing works
Self-citationFolkins, A. K., Jarboe, E. A., Saleemuddin, A., Lee, Y., Callahan, M. J., Drapkin, R., Garber, J. E., Muto, M. G., Tworoger, S. S., & Crum, C. P. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.012 · Cited by 292 · see citing works
Self-citationA Genetically Defined Model for Human Ovarian Cancer
Liu, J., Yang, G. S., Thompson-Lanza, J. A., Glassman, A. B., Hayes, K. J., Patterson, A. P., Marquez, R. T., Auersperg, N., Yu, Y., Hahn, W. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3380 · Cited by 273 · see citing works
PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma
Laury, A. R., Hornick, J. L., Perets, R., Krane, J. F., Corson, J. M., Drapkin, R., & Hirsch, M. S. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181da7687 · Cited by 229 · see citing works
Self-citationLevanon, K., Ng, V., Piao, H. Y., Zhang, Y., Chang, M. C., Roh, M. H., Kindelberger, D. W., Hirsch, M. S., Crum, C. P., Marto, J. A., et al. (2009) · Oncogene · doi:10.1038/onc.2009.402 · Cited by 213 · see citing works
Self-citationHereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
Lynch, H. T., Casey, M. J., Snyder, C., Bewtra, C., Lynch, J. F., Butts, M., & Godwin, A. K. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.02.004 · Cited by 205 · see citing works
Emerging roles for PAX8 in ovarian cancer and endosalpingeal development
Bowen, N. J., Logani, S., Dickerson, E. B., Kapa, L. B., Akhtar, M., Benigno, B. B., & McDonald, J. F. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.052 · Cited by 199 · see citing works
Kuo, K., Guan, B., Feng, Y., Mao, T., Chen, X., Jinawath, N., Wang, Y., Kurman, R. J., Shih, I., & Wang, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3913 · Cited by 196 · see citing works
Rane, S. G., Cosenza, S. C., Mettus, R. V., & Reddy, E. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.644-656.2002 · Cited by 167 · see citing works
Intercepting pelvic cancer in the distal fallopian tube: Theories and realities
Crum, C. P. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.01.004 · Cited by 167 · see citing works
Ramakrishna, M., Williams, L. H., Boyle, S. E., Bearfoot, J. L., Sridhar, A., Speed, T. P., Gorringe, K. L., & Campbell, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009983 · Cited by 112 · see citing works
Madore, J., Ren, F., Filali‐Mouhim, A., Sanchez, L. M., Köbel, M., Tonin, P. N., Huntsman, D. D., Provencher, D. M., & Mes‐Masson, A. (2009) · The Journal of Pathology · doi:10.1002/path.2659 · Cited by 108 · see citing works
Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes
Sasaki, R., Narisawa‐Saito, M., Yugawa, T., Fujita, M., Tashiro, H., Katabuchi, H., & Kiyono, T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp007 · Cited by 99 · see citing works
Haverty, P. M., Hon, L., Kaminker, J. S., Chant, J., & Zhang, Z. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-21 · Cited by 94 · see citing works
Nowee, M., Snijders, A., Rockx, D., de Wit, R., Kosma, V.-M., Hämäläinen, K. M., Schouten, J., Verheijen, R. H. M., van Diest, P. J., Albertson, D., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2217 · Cited by 93 · see citing works
Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
Gorringe, K. L., George, J., Anglesio, M. S., Ramakrishna, M., Etemadmoghadam, D., Cowin, P. A., Sridhar, A., Williams, L. H., Boyle, S. E., Yanaihara, N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011408 · Cited by 88 · see citing works
Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours
Dimova, I. I., Raitcheva, S., Dimitrov, R., Doganov, N., & Toncheva, D. I. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.022 · Cited by 48 · see citing works
Darcy, K. M., Brady, W. E., Blancato, J. K., Dickson, R. B., Hoskins, W. J., McGuire, W. P., & Birrer, M. J. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.012 · Cited by 35 · see citing works
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer
Khalil, I. G., BREWER, M. A., Neyarapally, T. A., & Runowicz, C. D. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.085 · Cited by 30 · see citing works
Zheng, J., Mercado‐Uribe, I., Rosen, D. G., Chang, B., Liu, P., Yang, G. S., Malpica, A. L., Naora, H., Auersperg, N., Mills, G. B., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.1.10264 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I. G., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. P., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3144 · Cited by 1,459 · see citing works
Self-citationRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D. L., Böhm, S., Ahmed, A. A., Aspuria, P.-J. P., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S. P., Bookman, M. A., et al. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4019 · Cited by 1,365 · see citing works
Self-citationPerets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596 · see citing works
Self-citationIron addiction: a novel therapeutic target in ovarian cancer
Basuli, D., Tesfay, L., Deng, Z., Paul, B., Yamamoto, Y., Ning, G., Xian, W., McKeon, F., Lynch, M. L., Crum, C. P., et al. (2017) · Oncogene · doi:10.1038/onc.2017.11 · Cited by 469 · see citing works
McAlpine, J. N., Hanley, G. E., Woo, M. M. M., Tone, A. A., Rozenberg, N., Swenerton, K. D., Gilks, C. B., Finlayson, S. J., Huntsman, D. D., & Miller, D. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.003 · Cited by 288 · see citing works
Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment
Hoffmann, K., Berger, H., Kulbe, H., Thillainadarasan, S., Mollenkopf, H., Żemojtel, T., TAUBE, E. T., Darb‐Esfahani, S., Mangler, M., Sehouli, J., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104013 · Cited by 252 · see citing works
Wang, Y., Li, L., Douville, C. B., Cohen, J. D., Yen, T., Kinde, I., Sundfelt, K., Kjær, S. K., Hruban, R. H., Shih, I., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap8793 · Cited by 245 · see citing works
S ociety of G ynecologic O ncology recommendations for the prevention of ovarian cancer
Walker, J. L., Powell, C. B., Chen, L.-M., Carter, J., Bae-Jump, V. L., Parker, L. P., Borowsky, M. E., & Gibb, R. K. (2015) · Cancer · doi:10.1002/cncr.29321 · Cited by 242 · see citing works
Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
Barger, C. J., Branick, C., Chee, L., & Karpf, A. R. (2019) · Cancers · doi:10.3390/cancers11020251 · Cited by 209 · see citing works
Epithelial ovarian cancer experimental models
Lengyel, E. R., Burdette, J. E., Kenny, H. A., Matei, D. E., Pilrose, J. M., Haluska, P., Nephew, K. P., Hales, D. B., & Stack, M. S. (2013) · Oncogene · doi:10.1038/onc.2013.321 · Cited by 209 · see citing works
Karst, A. M., Jones, P., Vena, N., Ligon, A. H., Liu, J. F., Hirsch, M. S., Etemadmoghadam, D., Bowtell, D. D. L., & Drapkin, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2247 · Cited by 207 · see citing works
Self-citationEmerging Roles of Claudins in Human Cancer
Kwon, M. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918148 · Cited by 206 · see citing works
Paik, D. Y., Janzen, D. M., Schafenacker, A. M., Velasco, V. S., Shung, M. S., Cheng, D., Huang, J., Witte, O. N., & Memarzadeh, S. (2012) · Stem Cells · doi:10.1002/stem.1207 · Cited by 193 · see citing works
Progesterone action in breast, uterine, and ovarian cancers
Diep, C. H., Daniel, A. R., Mauro, L. J., Knutson, T. P., & Lange, C. A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0252 · Cited by 191 · see citing works
New insights in the pathophysiology of ovarian cancer and implications for screening and prevention
Nezhat, F. R., Apostol, R., NEZHAT, C. R., & Pejovic, T. B. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.03.044 · Cited by 181 · see citing works
The Changing View of High-Grade Serous Ovarian Cancer
Berns, E. M. J. J., & Bowtell, D. D. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3911 · Cited by 170 · see citing works
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4
Ren, Y., Cheung, H. W., von Maltzhan, G., Agrawal, A., Cowley, G. S., Weir, B. A., Boehm, J. S., Tamayo, P., Karst, A. M., Liu, J. F., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003778 · Cited by 166 · see citing works
Self-citationPrimary culture and immortalization of human fallopian tube secretory epithelial cells
Karst, A. M., & Drapkin, R. (2012) · Nature Protocols · doi:10.1038/nprot.2012.097 · Cited by 165 · see citing works
Self-citationWang, Y.-C., Yo, Y.-T., Lee, H.-Y., Liao, Y.-P., Chao, T., Su, P., & Lai, H. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.015 · Cited by 163 · see citing works
TP53 mutations in epithelial ovarian cancer
Zhang, Y., Cao, L., Nguyen, D., & Lu, H. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.08.40 · Cited by 149 · see citing works
King, S. M., Hilliard, T. S., Wu, L. Y., Jaffe, R. C., Fazleabas, A. T., & Burdette, J. E. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0107 · Cited by 138 · see citing works
Iyer, S., Zhang, S., Yucel, S., Horn, H., Smith, S. G., Reinhardt, F., Hoefsmit, E., Assatova, B., Casado, J., Meinsohn, M.-C., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0818 · Cited by 136 · see citing works
Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
Davidowitz, R. A., Selfors, L. M., Iwanicki, M., Elias, K. M., Karst, A. M., Piao, H., Ince, T. A., Drage, M. G., Dering, J., Konecny, G. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69815 · Cited by 132 · see citing works
Self-citationRegulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4
Lin, X., Shang, X., Manorek, G., & Howell, S. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067496 · Cited by 127 · see citing works
Lessard-Anderson, C. R., Handlogten, K. S., Molitor, R. J., Dowdy, S. C., Cliby, W. A., Weaver, A. L., Sauver, J. L. S., & Bakkum-Gamez, J. N. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.005 · Cited by 123 · see citing works
Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer
Ren, H., Tan, Z., Zhu, X., Crosby, K., Haack, H., Ren, J., Beausoleil, S. A., Moritz, A., Innocenti, G., Rush, A. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3931 · Cited by 123 · see citing works
Szabova, L., Yin, C., Bupp, S., Guerin, T. M., Schlomer, J. J., Householder, D. B., Baran, M. L., Yi, M., Song, Y., Sun, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3834 · Cited by 122 · see citing works
It's Totally Tubular…Riding The New Wave of Ovarian Cancer Research
Perets, R., & Drapkin, R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1382 · Cited by 116 · see citing works
Self-citationFunctional neuronal circuits promote disease progression in cancer
Kovacs, A., Vermeer, D. W., Madeo, M., Reavis, H. D., Vermeer, S. J., Williamson, C. S., Rickel, A. P., Stamp, J., Lucido, C. T., Cain, J. T., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade4443 · Cited by 119 · see citing works
Self-citationGusev, A., Lawrenson, K., Lin, X., Junior, P. C. M. L., Kar, S., Vavra, K. C., Segato, F., Fonseca, M. A., Lee, J. M., Pejovic, T., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0395-x · Cited by 111 · see citing works
Dinh, H. Q., Lin, X., Abbasi, F., Nameki, R. A., Haro, M., Olingy, C. E., Chang, H. S. Y., Hernández, L., Gayther, S. A., Wright, K. N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108978 · Cited by 108 · see citing works
Tight Junction Proteins Claudin-3 and Claudin-4 Control Tumor Growth and Metastases
Shang, X., Lin, X., Alvarez, E. A., Manorek, G., & Howell, S. B. (2012) · Neoplasia · doi:10.1593/neo.12942 · Cited by 109 · see citing works
Dorayappan, K. D. P., Gardner, M. L., Hisey, C. L., Zingarelli, R. A., Smith, B. Q., Lightfoot, M. D. S., Gogna, R., Flannery, M. M., Hays, J. L., Hansford, D. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3538 · Cited by 109 · see citing works
Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
Ahmed, N., Abubaker, K., Findlay, J. K., & Quinn, M. A. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24317 · Cited by 105 · see citing works
Lenz, J. D., & Dillard, J. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02710 · Cited by 103 · see citing works
Bahar‐Shany, K., Brand, H., Sapoznik, S., Jacob‐Hirsch, J., Yung, Y., Korach, J., Perri, T., Cohen, Y., Hourvitz, A., & Levanon, K. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.015 · Cited by 102 · see citing works
Self-citationMhawech-Fauceglia, P., Yan, L., Sharifian, M., Ren, X., Liu, S., Kim, G., Gayther, S. A., Pejovic, T., & Lawrenson, K. (2015) · Cancer Microenvironment · doi:10.1007/s12307-014-0153-7 · Cited by 95 · see citing works
The role of the fallopian tube in ovarian cancer.
Tone, A. A., Salvador, S. C., Finlayson, S. J., Tinker, A. V., Kwon, J. S., Lee, C., Cohen, T., Ehlen, T., Lee, M. H., Carey, M. S., et al. (2012) · PubMed · Cited by 98 · see citing works
The post-reproductive Fallopian tube: better removed?
Dietl, J., Wischhusen, J., & Häusler, S. F. (2011) · Human Reproduction · doi:10.1093/humrep/der274 · Cited by 98 · see citing works
Coming into focus: the nonovarian origins of ovarian cancer
Dubeau, L., & Drapkin, R. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt308 · Cited by 97 · see citing works
Self-citationThe Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift
Reade, C. J., Mcvey, R., Tone, A. A., Finlayson, S. J., McAlpine, J. N., Fung‐Kee‐Fung, M., & Ferguson, S. E. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30659-9 · Cited by 95 · see citing works
Karst, A. M., Levanon, K., Duraisamy, S., Liu, J. F., Hirsch, M. S., Hecht, J. L., & Drapkin, R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.021 · Cited by 92 · see citing works
Self-citationPaffenholz, S. V., Salvagno, C., Ho, Y.-J., Limjoco, M., Baslan, T., Tian, S., Kulick, A. R., de Stanchina, E., Wilkinson, J. E., Barriga, F. M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117754119 · Cited by 90 · see citing works
Hanley, G. E., McAlpine, J. N., Pearce, C. L., & Miller, D. M. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.035 · Cited by 88 · see citing works
Huang, H.-S., Chu, S., Hsu, C., Chen, P., Ding, D., Chang, M.-Y., & Chu, T. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv132 · Cited by 89 · see citing works
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
Ahmed, N., Abubaker, K., & Findlay, J. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.06.002 · Cited by 86 · see citing works
Ramakrishnan, M., Mathur, S. R., & Mukhopadhyay, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0896 · Cited by 84 · see citing works
YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
Hua, G., Lv, X., He, C., Remmenga, S. W., Rodabough, K. J., Dong, J., Yang, L., Lele, S. M., Yang, P., Zhou, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.288 · Cited by 83 · see citing works
Self-citationAlkema, N. G., Wisman, G. B. A., van der Zee, A. G. J., van Vugt, M. A. T. M., & de Jong, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.005 · Cited by 80 · see citing works
Bhartiya, D., & Singh, J. (2014) · Reproduction · doi:10.1530/rep-14-0220 · Cited by 78 · see citing works
Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention
George, S. H. L., Garcia, R., & Slomovitz, B. M. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00108 · Cited by 77 · see citing works
Wang, Y., Sheng, Q., Spillman, M. A., Behbakht, K., & Gu, H. (2011) · Oncogene · doi:10.1038/onc.2011.435 · Cited by 75 · see citing works
In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells
Yamamoto, Y., Ning, G., Howitt, B. E., Mehra, K. K., Wu, L., Wang, X., Yue, H., Kern, F., Wei, T. S., Zhang, T., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4649 · Cited by 75 · see citing works
Air‐liquid interface cell culture: From airway epithelium to the female reproductive tract
Chen, S., & Schoen, J. (2019) · Reproduction in Domestic Animals · doi:10.1111/rda.13481 · Cited by 74 · see citing works
Guo, S. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.08.006 · Cited by 73 · see citing works
Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
Jazaeri, A. A., Bryant, J. L., Park, H., Li, H., Dahiya, N., Stoler, M. H., Ferriss, J. S., & Dutta, A. (2011) · Neoplasia · doi:10.1593/neo.11138 · Cited by 71 · see citing works
Identification of Quiescent, Stem-Like Cells in the Distal Female Reproductive Tract
Wang, Y., Sacchetti, A., van Dijk, M. R., van der Zee, M., van der Horst, P. H., Joosten, R., Burger, C. W., Grootegoed, J. A., Blok, L. J., & Fodde, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040691 · Cited by 70 · see citing works
Tang, Z., Ow, G. S., Thiery, J. P., Ivshina, A. V., & Kuznetsov, V. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28371 · Cited by 70 · see citing works
Janzen, D. M., Tiourin, E., Salehi, J. A., Paik, D. Y., Lu, J. N., Pellegrini, M. A., & Memarzadeh, S. (2015) · Nature Communications · doi:10.1038/ncomms8956 · Cited by 68 · see citing works
RetractedAhmed, N., Kadife, E., Raza, A., Short, M. K., Jubinsky, P. T., & Kannourakis, G. (2020) · Cells · doi:10.3390/cells9030719 · Cited by 68 · see citing works
Veigel, D., Wagner, R., Stübiger, G., Wuczkowski, M., Filipits, M., Horvat, R., Benhamú, B., López-Rodríguez, M. L., Leisser, A., Valent, P., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29261 · Cited by 67 · see citing works
Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66 · see citing works
Yamamoto, C. M., Oakes, M., Murakami, T., Muto, M. G., Berkowitz, R. S., & Ng, S. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0391-2 · Cited by 66 · see citing works
Lawrenson, K., Li, Q., Kar, S., Seo, J.-H., Tyrer, J. P., Spindler, T. J., Lee, J. S., Chen, Y., Karst, A. M., Drapkin, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms9234 · Cited by 65 · see citing works
Self-citationNagaraj, A. B., Knarr, M., Sekhar, S. C., Connor, R. S., Joseph, P. L., Kovalenko, O., Fleming, A., Surti, A., Nurmemmedov, E., Beltrame, L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2041 · Cited by 62 · see citing works
Salpingectomy for Sterilization
Powell, C. B., Alabaster, A. L., Simmons, S. R., Garcia, C., Martin, M., McBride-Allen, S., & Littell, R. D. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002312 · Cited by 62 · see citing works
Shang, S., Yang, J., Jazaeri, A. A., Duval, A. J., Tufan, T., Fischer, N. L., Benamar, M., Guessous, F., Lee, I.-Y., Campbell, R. M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0215 · Cited by 62 · see citing works
The origin of ovarian cancers - hypotheses and controversies
Auersperg, N. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s401 · Cited by 61 · see citing works
EGFR/HER-Targeted Therapeutics In Ovarian Cancer
Wilken, J. A., Badri, T., Cross, S., Raji, R., Santin, A. D., Schwartz, P. E., Branscum, A. J., Baron, A. T., Sakhitab, A. I., & Maihle, N. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.11 · Cited by 60 · see citing works
English, D. P.-G., & Santin, A. D. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510412 · Cited by 60 · see citing works
Hellner, K., Miranda, F., Fotso, D. C., Herrero‐González, S., Hayden, D. M., Tearle, R. G., Artibani, M., Carrami, E. M., Williams, R. M., Gaitskell, K. L., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.048 · Cited by 59 · see citing works
Lawrenson, K., Fonseca, M. A., Liu, A. Y., Dezem, F. S., Lee, J. M., Lin, X., Corona, R. I., Abbasi, F., Vavra, K. C., Dinh, H. Q., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.122 · Cited by 58 · see citing works
Self-citationElafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors
Labidi‐Galy, S. I., Clauss, A., Ng, V., Duraisamy, S., Elias, K. M., Piao, H.-Y., Bilal, E., Davidowitz, R. A., Lu, Y., Badalian‐Very, G., et al. (2014) · Oncogene · doi:10.1038/onc.2013.562 · Cited by 57 · see citing works
Self-citationIn vitro three-dimensional modeling of fallopian tube secretory epithelial cells
Lawrenson, K., Notaridou, M., Lee, N., Benjamin, E. O., Jacobs, I. J., Jones, C., & Gayther, S. A. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-43 · Cited by 57 · see citing works
Gloss, B., Patterson, K., Barton, C. A., Gonzalez, M., Scurry, J., Hacker, N. F., Sutherland, R. L., O’Brien, P. M., & Clark, S. J. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.003 · Cited by 57 · see citing works
Brown, C. W., Brodsky, A. S., & Freiman, R. N. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0334 · Cited by 56 · see citing works
Hooda, J., Novak, M., Salomon, M. P., Matsuba, C., Ramos, R. I., MacDuffie, E., Song, M., Hirsch, M. S., Lester, J., Parkash, V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2297 · Cited by 56 · see citing works
Self-citationMutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Iwanicki, M., Chen, H., Iavarone, C., Zervantonakis, I. K., Muranen, T. E., Novak, M., Ince, T. A., Drapkin, R., & Brugge, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.86829 · Cited by 54 · see citing works
Self-citationSurgical Implications of the Potential New Tubal Pathway for Ovarian Carcinogenesis
Chene, G., Rahimi, K., Mes‐Masson, A., & Provencher, D. M. (2013) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2012.11.010 · Cited by 53 · see citing works
Shang, X., Lin, X., Manorek, G., & Howell, S. B. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079798 · Cited by 53 · see citing works
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
Chakraborty, P. K., Xiong, X., Mustafi, S. B., Saha, S., Dhanasekaran, D. N., Mandal, N. A., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2015) · Oncotarget · doi:10.18632/oncotarget.5424 · Cited by 51 · see citing works
Mutant p53 expression in fallopian tube epithelium drives cell migration
Quartuccio, S. M., Karthikeyan, S., Eddie, S. L., Lantvit, D. D., hAinmhire, E. Ó., Modi, D., Wei, J., & Burdette, J. E. (2015) · International Journal of Cancer · doi:10.1002/ijc.29528 · Cited by 51 · see citing works
Hanley, G. E., Kwon, J. S., McAlpine, J. N., Huntsman, D. D., Finlayson, S. J., & Miller, D. M. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.02.005 · Cited by 51 · see citing works
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
Sato, S., Gillette, M. A., de Santiago, P. R., Kuhn, E. W., Burgess, M. W., Doucette, K., Feng, Y., Mendez‐Dorantes, C., Ippoliti, P. J., Hobday, S. B., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28840-5 · Cited by 50 · see citing works
Self-citationTu-be or not tu-be: That is the question… About serous ovarian carcinogenesis
Chene, G., Dauplat, J., Radosevic‐Robin, N., Cayre, A., & Penault-Llorca, F. M. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.004 · Cited by 50 · see citing works
Gene Expression Signature of Normal Cell-of-Origin Predicts Ovarian Tumor Outcomes
Merritt, M. A., Bentink, S., Schwede, M., Iwanicki, M., Quackenbush, J. F., Woo, T. Y. C., Agoston, E. S., Reinhardt, F., Crum, C. P., Berkowitz, R. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080314 · Cited by 50 · see citing works
Virant‐Klun, I., & Štimpfel, M. (2016) · Scientific Reports · doi:10.1038/srep34730 · Cited by 50 · see citing works
Mei, J., Tian, H., Huang, H.-S., Hsu, C., Liou, Y., Wu, N., Zhang, W., & Chu, T. (2021) · Cell Proliferation · doi:10.1111/cpr.13029 · Cited by 50 · see citing works
Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment
Watters, K. M., Bajwa, P., & Kenny, H. A. (2018) · Cancers · doi:10.3390/cancers10080265 · Cited by 49 · see citing works
Nameki, R. A., Chang, H. S. Y., Reddy, J., Corona, R. I., & Lawrenson, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107722 · Cited by 47 · see citing works
Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
Barger, C. J., Chee, L., Albahrani, M., Muñoz-Trujillo, C., Boghean, L., Branick, C., Odunsi, K. O., Drapkin, R., Zou, L., & Karpf, A. R. (2021) · eLife · doi:10.7554/elife.55070 · Cited by 47 · see citing works
Self-citationCoetzee, S. G., Shen, H. C., Hazelett, D. J., Lawrenson, K., Kuchenbaecker, K. B., Tyrer, J. P., Rhie, S. K., Levanon, K., Karst, A. M., Drapkin, R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv101 · Cited by 44 · see citing works
Self-citationJones, P., & Drapkin, R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00217 · Cited by 46 · see citing works
Self-citationEpigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors
Elias, K. M., Emori, M. M., Westerling, T., Long, H. W., Budina-Kolomets, A., Li, F., MacDuffie, E., Davis, M., Holman, A. G., Lawney, B. P., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87988 · Cited by 46 · see citing works
Self-citationTranslating next generation sequencing to practice: Opportunities and necessary steps
Kamalakaran, S., Varadan, V., Janevski, A., Banerjee, N., Tuck, D. P., McCombie, W. R., Dimitrova, N., & Harris, L. N. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.04.008 · Cited by 45 · see citing works
Liu, Y., Qiang, W., Xu, X., Dong, R., Karst, A. M., Liu, Z., Kong, B., Drapkin, R., & Wei, J. (2015) · Oncotarget · doi:10.18632/oncotarget.5493 · Cited by 45 · see citing works
Self-citationHereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2
Samuel, D., Diaz-Barbe, A., Pinto, A., Schlumbrecht, M. P., & George, S. H. L. (2022) · Cells · doi:10.3390/cells11030539 · Cited by 44 · see citing works
Hanley, G. E., Kwon, J. S., Finlayson, S. J., Huntsman, D. D., Miller, D. M., & McAlpine, J. N. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.05.019 · Cited by 44 · see citing works
In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene
Dunn, G. P., Cheung, H. W., Agarwalla, P. K., Thomas, S. R., Zektser, Y. A., Karst, A. M., Boehm, J. S., Weir, B. A., Berlin, A. M., Zou, L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311909111 · Cited by 43 · see citing works
Self-citationThe chicken model of spontaneous ovarian cancer
Hawkridge, A. M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300135 · Cited by 43 · see citing works
- Authors
- Karst, A. M., Levanon, K., & Drapkin, R.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-04-18
- Volume
- 108
- Issue
- 18
- Pages
- 7547-7552
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3088633
- OpenAlex
- W2071014344
- Cited by
- 280
- References
- 37
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 6 · 2023: 14 · 2022: 9 · 2021: 19 · 2020: 12 · 2019: 22 · 2018: 22 · 2017: 11 · 2016: 25 · 2015: 28 · 2014: 30 · 2013: 27 · 2012: 26
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- National Cancer Institute (P50CA105009)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- high-grade serous ovarian cancer, fallopian tube epithelium, secretory epithelial cells, carcinogenesis, cell transformation, hTERT immortalization, oncogenic Ras, c-Myc, p53, CDK4, Müllerian carcinoma, xenograft tumorigenicity, ovarian surface epithelium
- MeSH terms
- Antigens, Polyomavirus Transforming, Carcinoma, Cell Transformation, Neoplastic, Epithelial Cells, Fallopian Tubes, Female, Humans, Immunohistochemistry, Microscopy, Fluorescence, Ovarian Neoplasms, Tumor Stem Cell Assay, Blotting, Western, Carcinogenicity Tests, Telomerase, Cell Line, Tumor, Comparative Genomic Hybridization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
